OAM
GOSS icon

Oxford Asset Management’s Gossamer Bio GOSS Stock Holding History

Oxford Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-59,908
Closed -$1.33M – 1810
2019
Q2 		$1.33M Sell
59,908
-92,473
-61% -$1.77M 0.03% 836
2019
Q1 		$3.3M Buy
+152,381
New +$3.18M 0.07% 347

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oxford Asset Management's GOSS Position: Q3 2019 in Review

Oxford Asset Management sold out of Gossamer Bio (GOSS) in Q3 2019, closing a stake of 59,908 shares — an estimated $1.33M sold.

Oxford Asset Management first reported a position in GOSS in Q1 2019 and held it in 2 quarters. The position peaked at $3.3M in Q1 2019. 79 funds tracked by Wall St. Rank hold GOSS as of Q3 2019.

  • Oxford Asset Management reported no remaining Gossamer Bio position as of Q3 2019 after selling out during the quarter.
  • Oxford Asset Management sold 59,908 Gossamer Bio shares in Q3 2019, an estimated $1.33M.
  • Oxford Asset Management first reported a position in Gossamer Bio in Q1 2019 and held it in 2 quarters.
  • Oxford Asset Management's Gossamer Bio position peaked at $3.3M in Q1 2019.
  • 79 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.